Summary
The 24-month results of the European cohort of the Resynchronization Reverses Remodeling in Systolic left ventricular dysfunction [REVERSE; NCT00271154] trial showed that CRT that is combined with optimal medical therapy (OMT) produces improved clinical outcomes, as well as improved ventricular structure and function in persons with NYHA Class I-II HF patients.
- Interventional Techniques & Devices
- Heart Failure Clinical Trials
- © 2009 MD Conference Express
Tools
Adding Cardiac Resynchronization Therapy (CRT) May Prevent Disease Progression in Asymptomatic and Mildly Symptomatic Heart Failure (HF) Patients Already on OMT
Permalink:
Table of contents
Cited By...
- No citing articles found.